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Although many genes predisposing to autism spec-
trum disorders (ASD) have been identified, the bio-
logical mechanism(s) remain unclear. Mouse models
based on human disease-causing mutations provide
the potential for understanding gene function and
novel treatment development. Here, we characterize
a mouse knockout of the Cntnap2 gene, which is
strongly associated with ASD and allied neurodeve-
lopmental disorders. Cntnap2/ mice show deficits
in the three core ASD behavioral domains, as well as
hyperactivity and epileptic seizures, as have been re-
ported in humans with CNTNAP2 mutations. Neuro-
pathological and physiological analyses of these
mice before the onset of seizures reveal neuronal
migration abnormalities, reduced number of inter-
neurons, and abnormal neuronal network activity.
In addition, treatment with the FDA-approved drug
risperidone ameliorates the targeted repetitive
behaviors in the mutant mice. These data demon-
strate a functional role for CNTNAP2 in brain devel-
opment and provide a new tool for mechanistic and
therapeutic research in ASD.
INTRODUCTION
Autism spectrum disorders (ASD) form a heterogeneous neuro-
developmental syndrome characterized by deficits in language
development, social interactions, and repetitive behavior/
restricted interests (APA, 2000). Although not necessary for
diagnosis, a number of other neurological or behavioral abnor-
malities are frequently associated with ASD, including hyperac-tivity, epilepsy, and sensory processing abnormalities (Gesch-
wind, 2009).
Research into the genetic basis for ASD has identified many
genes, including common and rare variants (Sebat et al., 2007;
Glessner et al., 2009; Weiss et al., 2009). Association, linkage,
gene expression, and imaging data support the role of both
common and rare variants of contactin associated protein-like
2 (CNTNAP2) in ASD. Originally, a recessive nonsense mutation
in CNTNAP2 was shown to cause a syndromic form of ASD,
cortical dysplasia-focal epilepsy syndrome (CDFE), a rare
disorder resulting in epileptic seizures, language regression,
intellectual disability, hyperactivity, and, in nearly two-thirds of
the patients, autism (Strauss et al., 2006). Several reports have
since linked this gene to an increased risk of autism or autism-
related endophenotypes (Alarco´n et al., 2008; Arking et al.,
2008; Bakkaloglu et al., 2008; Vernes et al., 2008). Recently,
we have shown that the same CNTNAP2 variant that increases
risk for the language endophenotype in autism leads to abnormal
functional brain connectivity in human subjects (Scott-Van
Zeeland et al., 2010), consistent with emerging theories of ASD
pathophysiology based on altered neuronal synchrony and
disconnection (Belmonte et al., 2004).
Cntnap2 (also known as Caspr2) encodes a neuronal trans-
membrane protein member of the neurexin superfamily involved
in neuron-glia interactions and clustering of K+ channels in
myelinated axons (Poliak et al., 1999; 2003). However, the fact
that the gene is expressed embryonically (Poliak et al., 1999;
Abrahams et al., 2007; Alarco´n et al., 2008) andmyelination takes
place postnatally, together with the increasing number of reports
that link thegene toASD, suggest an additional role forCNTNAP2
in early brain development. This is supported by the imaging and
pathology data in patients with CDFE, in whom nearly half mani-
fest presumed neuronal migration abnormalities on MRI, con-
firmed by histological analysis of brain tissue resected from
patientswhounderwent surgery for epilepsy (Strausset al., 2006).Cell 147, 235–246, September 30, 2011 ª2011 Elsevier Inc. 235
The generation of valid animal models is critical for under-
standing the pathophysiology of ASD and to assess the potential
of proposed treatments, as well as developing new, effective
interventions. Ideally, mouse models should be based on
a known genetic cause of the disease (construct validity), reflect
key aspects of the human symptoms (face validity), and respond
to treatments that are effective in the human disease (predictive
validity) (Chadman et al., 2009; Nestler and Hyman, 2010). Here,
we demonstrate that the Cntnap2 knockout mouse exhibits
striking parallels to the major neuropathological features in
CDFE and the core features of ASD. We observe defects in the
migration of cortical projection neurons and a reduction in the
number of GABAergic interneurons, as well as accompanying
neurophysiological alterations. These data show that CNTNAP2
is involved in the development of cortical circuits and further
support alterations in brain synchrony or connectivity in ASD
pathophysiology. In addition, treating Cntnap2/ mice with ris-
peridone rescues the repetitive behavior, but not the social
deficits, a dissociation parallel to what is seen in human patients.
These data demonstrate the validity of the Cntnap2 KO as
a mouse model for ASD and provide initial insight into the under-
lying mechanisms by which CNTNAP2 affects brain develop-
ment and function.
RESULTS
Expression of Cntnap2 in Mouse Brain
Mutant mice lacking the Cntnap2 gene (Caspr2 null mice) were
generated by Dr. Elior Peles (Poliak et al., 2003). We back-
crossed the original ICR outbred strain onto the C57BL/6J
background for 10–12 generations. Cntnap2/ mice on the
C57BL/6J background had a normal appearance; no differences
in weight or growth rate were observed when compared with WT
littermates. In WT brain, expression of CNTNAP2 was first
detected by western blot around embryonic day 14 (E14). As
expected, CNTNAP2 was completely absent in the brain of
homozygous mutant animals (Figure S1A available online). In
situ hybridization demonstrated Cntnap2 expression in multiple
adult brain regions, primarily cerebral cortex, hippocampus,
striatum, olfactory tract, and cerebellar cortex (Figure S1B).
Embryonic expression was also broad, including the ventricular
proliferative zones of the developing cortex and ganglionic
eminences (where excitatory projection neurons and inhibitory
interneurons arise, respectively) overlapping with regions con-
taining migrating neurons and postmigratory cells, indicating
a possible role in neuron development and/or migration
(Figure S1C).
Cntnap2/ Mice Exhibit Epileptic Seizures
and Abnormal Electroencephalogram Pattern
One of the major phenotypes of CDFE syndrome is the presence
of epileptic seizures, which is associated with dense hippo-
campal astroglyosis (Strauss et al., 2006). In Cntnap2/ mice,
spontaneous seizures were commonly observed in animals older
than 6 months of age. Seizures were consistently induced by
mild stressors during routine handling (Movie S1). A behavioral
study of the frequency and severity of the seizures (Racine,
1972) is presented in Table S1. Histological analysis of the hippo-236 Cell 147, 235–246, September 30, 2011 ª2011 Elsevier Inc.campal formation in these animals did not show any gross struc-
tural abnormalities, although a reduction in parvalbumin-positive
interneurons was found (see below and Figure S3C). Reactive
astrocytosis as indicated by an enhanced expression of glial
fibrillary acidic protein (GFAP) was observed throughout the
hippocampus of mutant mice after the onset of seizures. Reac-
tive astrocytosis was especially dense in the hilus but was not
accompanied by neuronal loss in this structure as indicated by
neuronal nuclei (NeuN) staining (Figure 1A). Electroencephalo-
gram (EEG) recordings from freely moving mutant animals im-
planted with cortical electrodes at 8 months of age showed
generalized interictal spike discharges during slow-wave sleep,
whereas no electrical abnormalities were found in the EEG of
mutant mice at times before the onset of seizures (Figure 1B).
To avoid any confounding effect due to the presence of epileptic
seizures, the following neuropathological, physiological, and
behavioral characterization of Cntnap2 mutants was performed
at an age before the onset of seizures.
Cntnap2/ Mice Show Neuronal Migration
Abnormalities
We performed detailed histological analyses of Cntnap2 KO
brain and found no gross morphological changes in the brain
structure of mutant animals by conventional staining techniques
(cresyl violet staining), consistent with previous reports (Poliak
et al., 2003). NeuN immunohistochemistry (IHC) revealed the
presence of ectopic neurons in the corpus callosum of mutant
mice at postnatal day 14 (P14), after neuronal migration is
completed, which persisted through adulthood (Figure 2A). Inter-
estingly, ectopic neurons of unknown origin in white matter were
also reported in CDFE syndrome patients (Strauss et al., 2006).
Patients with CDFE syndrome also show neuronal migration
abnormalities, such as abnormal arrangements of neurons in
clusters or migratory rows in the deep layers of cortex (Strauss
et al., 2006). We assessed laminar positioning of cortical projec-
tion neurons in WT and Cntnap2 KO mice with antibodies
against CUX1, a marker for upper-cortical layers, and FOXP2,
a marker for deep cortical layers (Molyneaux et al., 2007).
Cntnap2/ mice show significantly higher numbers of CUX1+
cells in deep cortical layers (V and VI; Figure 2B). In contrast,
deeper-layer FOXP2+ cells show the same pattern in both geno-
types (Figure S2).
We performed BrdU neuron birthdating at E16.5, after the birth
of layer V neurons (Angevine and Sidman, 1961) to confirm that
the CUX1+ ectopic neurons observed in deep cortical layers
were being born concomitant with superficial cell identity and
their presence was not due to changes in cell fate. Sections of
E16.5-labeled animals were analyzed at P7, when cortical lami-
nation is essentially complete. As shown in Figure 2C, the distri-
bution of BrdU+ cells is significantly different between WT and
KO littermates, the latter showing a shortage of cells in upper-
cortical layers that are redistributed to lower cortical layers.
These data indicate that CNTNAP2 is necessary for the normal
migration of cortical projection neurons.
Reduced Number of Interneurons in Cntnap2/ Mice
Since the identification of CNTNAP2 (CASPR2) in 1999 (Poliak
et al., 1999), its expression has been reported mainly in
Figure 1. Cntnap2/ Mice Show Epileptic
Seizures and Abnormal EEG Pattern
(A) Presence of reactive astrocytes in the hippo-
campal hilus (inset) of P180, but not P14, mutant
mice without significant changes in neuronal
density. GFAP, glial fibrillary acidic protein; NeuN,
neuronal nuclei. Scale bar, 50 mm. GFAP quanti-
fication is shown as percentage of area occupied
by reactive astrocytes. n = 4 mice/genotype for
each age. Data are presented as mean ± SEM.
***p < 0.001.
(B) EEG recording from mutant mice shows
abnormal spike discharges (arrows) after seizure
onset. n = 3 mice for each age. RF, right frontal;
RP, right parietal.
See also Table S1, Movie S1 and Figure S3C.excitatory pyramidal cells at the axon initial segment (Inda
et al., 2006) and myelinated axons (Poliak et al., 2003, Horresh
et al., 2008). The embryonic expression of Cntnap2 in the gangli-
onic eminence, where GABAergic interneurons arise, led us
to analyze the expression of CNTNAP2 in interneurons. We
analyzed available microarray data from single glutamatergic
and GABAergic neuronal populations isolated from adult mice
(Sugino et al., 2006) using weighted gene coexpression network
analysis (WGCNA) (Zhang and Horvath, 2005). WGCNA groups
functionally related genes into modules based on expression in
a way such that genes showing similar expression patterns
across samples are grouped together. Modules are likely to
represent biological pathways in a way that they are usually cor-
egulated or interact (Oldham et al., 2008). Interestingly, we found
that Cntnap2 is part of a module with enriched expression in
inhibitory relative to excitatory neurons (Figure S3A and Table
S2). In addition, three of the most highly connected genes within
the module, which are indicative of module function, are Gad1,
Gad2, and Slc32a1 (VGAT), genes that are known to be neces-
sary for GABAergic transmission (Figure 3A), suggesting the
possibility of CNTNAP2 involvement in interneuron functioning.
Because the potential relationship of CNTNAP2 to GABAergic
interneuron function had not been previously explored and
interneuron dysfunction has been associated with autism andCell 147, 235–246, Seepilepsy (Levitt et al., 2004), we analyzed
the number and distribution of interneu-
rons in Cntnap2/mice. GAD1 immuno-
staining showed that Cntnap2/ mice
have a reduced number of GABAergic
interneurons in all laminae (Figure 3B).
To test whether the reduction in interneu-
rons was subtype specific, we analyzed
the number and distribution of the largely
nonoverlapping subgroups of interneu-
rons in rodents: parvalbumin (PVALB),
calretinin (CALB2) and neuropeptide Y
(NPY) (Wonders and Anderson, 2006).
We observed that PVALB+ interneurons
were the most affected (Figure 3C).
Because striatal interneurons are also
born in the ganglionic eminence (Marı´net al., 2001), we next examined the number of interneurons in
the striatum. We observed a reduction of striatal GABAergic
interneurons in mutants (Figure 3D) without a change in cholin-
ergic interneurons (Figure S3B). PVALB+ interneurons were
also reduced in the hippocampus (Figure S3C). Together, these
data indicate a role for CNTNAP2 in GABAergic interneuron
development.
Cntnap2/ Mice Show Reduced Cortical Neuronal
Synchrony
The abnormal positioning and migration of excitatory principal
neurons and reduction in inhibitory interneurons suggested
that neuronal network activity might be abnormal. This was
particularly important, as GABAergic interneurons are recog-
nized as playing a crucial role in the precise timing of neuronal
activity (Sohal et al., 2009) and there is increasing evidence of
abnormal neural synchrony as a pathophysiological mechanism
in ASD (Uhlhaas and Singer, 2006; Belmonte et al., 2004). In vivo
two-photon calcium imaging of layer II/III neurons from somato-
sensory cortex (Figure 4A) indicated that the neuronal firing
pattern of Cntnap2/ mice was highly asynchronous relative
to WT mice (Figure 4B). The mean correlation coefficient of
the firing timing between all cell pairs of neurons over the
distance range analyzed was significantly lower in mutant miceptember 30, 2011 ª2011 Elsevier Inc. 237
Figure 2. Cntnap2/ Mice Show Neuronal
Migration Abnormalities
(A) Presence of ectopic neurons in the corpus
callosum of Cntnap2/ mice. NeuN, neuronal
nuclei; CTX, cortex; STR, striatum. Scale bar,
20 mm.
(B) Expression of Cux1, a marker for upper-layer
projection neurons, in somatosensory cortex of
WT and Cntnap2/ mice. Note the abnormal
distribution of CUX1-positive cells in groups
(arrowheads) and rows (arrow) in deep cortical
layers of mutant mice. Scale bar, 50 mm.
(C) Neuronal birthdating analysis. BrdU injected at
E16.5 was immunostained at P7. Note abnormal
distribution of neurons in groups (arrowheads) and
rows (arrow) in deep cortical layers of mutant
animals. Scale bar, 50 mm.
Data are presented as mean ± SEM. *p < 0.05,
**p < 0.01, ***p < 0.001. n = 3 mice/genotype for
each age. See also Figure S2.(Figure 4C). In addition, neither the average firing amplitude (Fig-
ure 4D) nor the average firing rate (Figure 4E) changed signifi-
cantly between genotypes, suggesting that the asynchronous
firing observed in mutant animals is likely due to a network
dysfunction rather than to abnormalities in neuronal activity or
conduction per se. This is consistent with previous data that
show no alterations in peripheral and central nerve conductance
in Cntnap2/ mice (Poliak et al., 2003).
Behavioral Characterization of Cntnap2/ Mice
Because the diagnostic criteria in ASD are currently based on
behavioral symptoms rather than molecular or neuroanatomical
indicators, we performed a complete battery of behavioral tests
to examine the potential effect of the absence of CNTNAP2 on
behavior. A summary of the tests performed relevant to each
behavioral domain related to ASD (Silverman et al., 2010), and
the results obtained are presented in Table S3.
Cntnap2/ mice displayed significantly greater locomotor
activity than their WT littermates in the open field test (Figures
S4A and S4B). This increased activity was also noted when
testing for motor coordination and balance with the rotorod, as
mutantmice performed significantly better thanWT (Figure S4C).
Interestingly, several animal models of autism (Kwon et al., 2006;238 Cell 147, 235–246, September 30, 2011 ª2011 Elsevier Inc.Nakatani et al., 2009) and hyperactivity
(Gerlai et al., 2000; Vitali and Clarke,
2004) have been reported to perform
better in the rotorod test.
To assess anxiety-related responses,
we performed the light-dark exploration
test and observed no significant differ-
ences between genotypes (Figure S4D).
Potential sensory deficits were assessed
with the hot plate test. As shown (Fig-
ure S4E),Cntnap2/mice demonstrated
hyperreactivity to thermal sensory stimuli.
To further characterize this sensory
deficit, we measured the acoustic startleresponse (Figure S4F) and the degree of prepulse inhibition (Fig-
ure S4G) and found no significant differences between geno-
types. In addition, olfaction analysis did not show any deficit in
mutant mice but, rather, appeared to perform better than WT
mice in the buried food test (Figure S4H).
Cntnap2/ Mice Show Stereotypic Motor Movements
and Behavioral Inflexibility
Spatial learning and memory were evaluated in the Morris water
maze (MWM). Both WT and mutant mice showed similar learning
curves, represented as time to locate the platform in the training
phase of the test (Figure 5A). Probe trials were performed the
day after the last training trial, and an active search for the platform
wasevaluated.Asexpected from their learningcurves,WTandKO
animals performed similarly in the probe test (Figures 5B and 5C).
To assess behavioral flexibility and perseveration, we first per-
formed a classic reversal task using the MWM. We found that
Cntnap2/ mice showed impairment in learning the new loca-
tion of the platform (Figure 5D) and performed poorly in the probe
test (Figures 5E and 5F). To study perseveration in more detail,
we performed the spontaneous alternation T maze test. As
shown in Figure 5G, Cntnap2/ mice showed significantly
higher number of no alternations in a standard 10 trial test,
Figure 3. Reduced Number of GABAergic
Interneurons in Cntnap2/ Mice
(A) Network plot showing the top 300 connections
within the Cntnap2 module.
(B) Expression of Gad1 at P14 shows a reduced
number of GABAergic interneurons in somato-
sensory cortex of KO mice. Scale bar, 50 mm.
(C) Expression of the interneuron markers PVALB,
CALB2, and NPY at P14. Scale bar, 50 mm.
(D) Expression of the GABAergic markers PVALB
and NPY in striatum. Scale bar, 100 mm. Inter-
neuron quantification is shown as percentage of
WT.
*p < 0.05 and **p < 0.01. For (B)–(E), n = 4 mice/
genotype. Data are presented as mean ± SEM.
See also Table S2 and Figure S3.confirming the perseveration observed in the reversal task on the
MWM. In addition to perseveration, repetitive behavior also
encompasses motor stereotypies, and both tend to co-occur
in children with ASD. Consistent with our other observations,
we found that Cntnap2/ mice spent almost three times more
time grooming themselves than their WT littermates (Figure 5H).
Cntnap2/ Mice Show Communication and Social
Behavior Abnormalities
Isolation-induced ultrasonic vocalizations (UsVs) are distress
calls emitted by pups when separated from their mother, repre-
senting an infant-mother vocal communicative behavior that is
thought to be relevant to ASD (Crawley, 2007; Silverman et al.,
2010). We analyzed the pattern of UsV emission in WT and
Cntnap2/mice through development (P3, P6, P9, and P12;
Scattoni et al., 2009) and found that Cntnap2/ mice emitted
a significantly lower number of ultrasonic calls than WT litter-
mates at all ages (Figure 6A).
We next analyzed social behavior in pairs of unfamiliar mice at
age P21 (juvenile play test). As shown in Figure 6B, Cntnap2/Cell 147, 235–246, Semice spent significantly less time inter-
acting with each other and instead
showed increased repetitive behaviors
such as grooming and digging. We con-
firmed that the abnormal social behavior
was not due to an olfaction defect (Table
S3), as Cntnap2 mutant mice actually
perform significantly better than WT in
theburied foodolfaction test (FigureS4H).
We also performed a three-chamber
social interaction test in adults (Crawley,
2007). As expected for the highly social
strain C57/B6J, WT mice showed a
highly significant preference for the cup
with a mouse, whereas KO mice did
not show a significant preference (Fig-
ure 6C). Finally, we examined nest-
building behavior, which is relevant to
home-cage social behaviors and medi-
ated by dopaminergic function in mice
(Szczypka et al., 2001). Cntnap2/mice were also significantly impaired in this task (Deacon,
2006), scoring less than half of the WT criterion (Figure 6D).
The Atypical Antipsychotic Risperidone Rescues
the Hyperactivity, Repetitive Behavior/Perseveration,
and Nesting Deficits in Cntnap2/ Mice
An important goal in developing mouse models of neuropsychi-
atric diseases is testing therapeutic treatments. Risperidone was
the first drug approved by the United States Food and Drug
Administration (FDA) for symptomatic treatment of ASD, allevi-
ating hyperactivity, repetitive behavior, aggression, and self-inju-
rious behavior (McDougle et al., 2000, 2008). Cntnap2/ mice
and their WT littermates were treated with risperidone or vehicle
for 7–10 days and were tested for improvement in behavior.
There were no significant changes in open field activity in treated
WT mice, indicating that the dose used for treatment was not
sedating (Figures 7A and 7B). However, risperidone decreased
the activity levels of Cntnap2/ mice to normal WT levels
(Figures 7A and 7B). Consistent with the lack of a sedative effect,
treated KO mice improved their nest-building score as well,ptember 30, 2011 ª2011 Elsevier Inc. 239
Figure 4. Reduced Neuronal Synchroniza-
tion in Cntnap2/ Mice
(A) Representative images of the calcium (top) and
astrocytic (bottom) signals of a 3 min movie stack.
OGB-1, Oregon green-1; SR-101, sulforhod-
amine-101.
(B) Correlation coefficient of neuronal firing for
every pair of neurons over cell distance.
(C) Mean correlation coefficient over the distance
range analyzed (240 mm).
(D) Firing amplitude presented as the summed
fluorescence change across all imaged cells in
a 3 min time window.
(E) Mean number of firing events per cell in a 3 min
time window. n = 4 mice/genotype. Data are pre-
sented as mean ± SEM.
***p < 0.001.a task that depends upon sustained activity (Figure 7C). Risper-
idone also reversed the increased grooming behavior of
Cntnap2/ mice (Figure 7E) and perseveration in the T maze
(Figure 7F). To assess any effect of risperidone on social
behavior, we performed the three- chamber social interaction
test and found no improvement with treatment (Figure 7G); nor
did we find improvement in sensory hypersensitivity (Figure 7D).
DISCUSSION
The development of mousemodels of ASD is crucial to study the
disorder at the molecular level, gain insight into disease mecha-
nisms, and test potential pharmacological interventions. Here,
we show that the consequences of CNTNAP2 deficiency in the240 Cell 147, 235–246, September 30, 2011 ª2011 Elsevier Inc.mouse resemble many of the behavioral
and cognitive features observed in
patients with idiopathic autism and of
the pathological features observed in
patients with recessive CNTNAP2 muta-
tions that cause a Mendelian form of
syndromic autism (Strauss et al., 2006).
Cntnap2/ mice have normal anxiety-
related responses, visual spatial memory,
and sensorimotor integration but show
abnormal vocal communication, repeti-
tive and restrictive behaviors, and ab-
normal social interactions. In addition,
they also show hyperactivity and epileptic
seizures, both features described in
CDFE patients and in many patients with
ASD. Heterozygous animals did not
show any of the behavioral (Figure S5) or
neuropathological (data not shown)
abnormalities observed in homozygote
knockouts; nor did they develop epileptic
seizures, consistent with the recessive
nature of the pathology in humans.
Autism and epilepsy are neurodevelop-
mental syndromes with a high frequency
of co-occurrence (Geschwind, 2009),which suggests shared underlying mechanisms. At a molecular
level, CNTNAP2 is a single pass transmembrane protein with
a short cytoplasmic region involved in clustering K+ channels
at juxtaparanodes in myelinated axons (Horresh et al., 2008)
and a long extracellular region that forms a neuron-glia cell adhe-
sion complex with contactin 2 (CNTN2, also known as TAG-1),
which is necessary for the proper localization of K+ channels in
this structure (Poliak et al., 2003). Thus, defects in myelination
and K+ channel mislocalization at the nodes of Ranvier could
theoretically lead to epilepsy in Cntnap2/ mice. However,
this is not likely the case, as both light microscopic and ultra-
structural analysis using electron microscopy in the peripheral
and central nerves in CNTNAP2-deficient mice (Poliak et al.,
2003) showed that nodal morphology and myelination were
Figure 5. Cntnap2/ Show Motor Stereotypic Movements and Behavioral Inflexibility
(A–F) Morris water maze (MWM) test. (A–C) Learning. (D–F) Reversal learning.
(A) Learning curve as indicated by the latency to locate a hidden platform (up to 60 s) during a 5 day training period. The average of four trials per day is presented.
(B) Probe test (the platform is removed), showing the percentage of time spent in each pool quadrant (in 60 s). Note that both genotypes spend significantly more
time in the target quadrant. TA, target; AR, adjacent right; AL, adjacent left; OP, opposite.
(C) Number of platform site crossings during the probe test.
(D) Learning curve for the reversal task of the MWM test, showing the latency to locate the new platform.
(E) Probe test. Note that WT, but not KO, mice spend significantly more time in the target quadrant.
(F) Number of platform site crossings during the probe test.
(G) Number of no alternations in the T maze spontaneous alternation test (10 trials).
(H) Time spent grooming over a 10 min period.
*p < 0.05. n = 10 mice/genotype. Data are presented as mean ± SEM. See also Table S3 and Figure S4.normal. In addition, electrophysiological investigation of nerve
conductance revealed no abnormalities in conduction velocity,
refractory period, or excitability (Poliak et al., 2003). In the current
study, neuropathological analysis of Cntnap2/ mice revealed
twomajor mechanisms that have been shown to lead to epilepsy
in humans, cortical neuronal migration abnormalities and a
reduction in the number of GABAergic interneurons. Whereas
neuronal migration abnormalities might have been expected
based on observations in patients with CDFE syndrome, thereduction in GABAergic neurons was unexpected, as CNTNAP2
has not been previously associated with GABAergic neuronal
function and no such deficit has been demonstrated in CDFE.
These data suggest that assessment of interneurons in patients
with CDFE would be worthwhile. Further, whether this reduction
in interneurons is also due to a migration defect or, rather, to
a defect in neurogenesis, differentiation, and/or survival remains
to be elucidated in future work. Nevertheless, the embryonic
expression of the gene in the ganglionic eminences and inCell 147, 235–246, September 30, 2011 ª2011 Elsevier Inc. 241
Figure 6. Cntnap2/ Mice Show Communication
and Social Behavior Abnormalities
(A) UsV. Number of calls from pups when separated from
their mother at P3, P6, P9, and P12 (5 min).
(B) Juvenile play. Time involved in social interaction, as
well as repetitive behaviors (grooming and digging) in pairs
of mice matched in genotype and sex at age P21 (10 min).
(C) Three-chamber social interaction test. Time interacting
with either an unfamiliar mouse or an inanimate object
(empty cup) in 10 min.
(D) Nesting behavior. The nesting score represents the
amount of nesting material used after a 16 hr period
(1, poor; 5, good).
n = 10 mice/genotype. Data are presented as mean ±
SEM. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S5.migrating interneurons supports a role for CNTNAP2 in the early
development and migration of these cells.
The large extracellular domain of CNTNAP2 is composed of
a number of protein-protein interaction domains that are
common to cell adhesion molecules, including laminin G, EGF
repeats, and discoidin-like domains (Poliak et al., 1999). During
myelination, CNTNAP2 localizes to the developing nodes of
Ranvier, where, as previously mentioned, it interacts extracellu-
larly with CNTN2. Interestingly, CNTN2 is also expressed embry-
onically, and blocking its function results in migration abnormal-
ities of cortical pioneer neurons and GABAergic interneurons
(Denaxa et al., 2001; Morante-Oria et al., 2003), although normal
numbers of interneurons were reported in CNTN2 deficient mice,
likely due to compensatory mechanisms (Denaxa et al., 2005).
Thus, analysis of CNTNAP2 interactors, including CNTN2, during
embryogenesis could provide insight to the role of CNTNAP2 in
neuronal migration.
One physiological consequence of the observed neuropa-
thology caused by Cntnap2 knockout is significantly reduced
neuronal synchronization. It is generally accepted that most
cognitive functions are based on the coordinated interactions
of large neuronal ensembles within and across different special-
ized brain areas (Uhlhaas and Singer, 2006). Synchronization
determines the pattern of neuronal interactions in a way that
effective neuronal connectivity would diminish when synchroni-
zation is less precise (Womelsdorf et al., 2007). A number of
functional neuroimaging studies have reported reduced connec-
tivity in ASD (Just et al., 2004; Villalobos et al., 2005; Cherkassky
et al., 2006; Damarla et al., 2010), supporting the notion that the
deficits in cognition and behavior associated with ASD are most
likely the result of a developmental disconnection (Geschwind
and Levitt, 2007). Interestingly, we have recently associated
common genetic risk variants in CNTNAP2 with abnormal func-
tional brain connectivity in humans (Scott-Van Zeeland et al.,
2010). Our observations of migration abnormalities and reduced
number of GABAergic interneurons inCntnap2/mice, together242 Cell 147, 235–246, September 30, 2011 ª2011 Elsevier Inc.with the normal global neuronal activity as
measured by the firing rate and amplitude,
suggest an abnormal neuronal circuit architec-
ture as the cause of the asynchronous firing
pattern, rather than abnormalities in neuronal
function per se. There are a number of factorsthat contribute to the precise timing of neural activity (reviewed
in Wang, 2010). Interestingly, GABAergic interneurons, in partic-
ular PVALB interneurons, have been reported to play a crucial
role in the rhythmic pacing of cortical neuronal activity (Sohal
et al., 2009). Therefore, further studies analyzing the structure
of neuronal networks and interneuron function in Cntnap2/
mice may have important implications for both the potential
understanding and treatment of ASD.
The ultimate goal of understanding the pathophysiology of the
disorder is to develop therapeutic interventions that improve or
restore normal brain activity and, ultimately, the associated
cognitive and behavioral deficits. Recent studies in mouse
models are very encouraging in this regard, including Rett
syndrome (Guy et al., 2007), fragile X syndrome (Do¨len et al.,
2007), neurofibromatosis type 1 (Costa et al., 2002), Down’s
syndrome (Fernandez et al., 2007), and tuberous sclerosis
(Ehninger et al., 2008). Here, we have shown that risperidone
efficiently reduces hyperactivity, motor stereotypies, and per-
severation in Cntnap2/ mice while having no effect on socia-
bility. This observation provides evidence that different path-
ways lead to the ASD-associated core domains of social and
repetitive behavior observed in this mouse model, parallel to
the situation in humans, and supports the validity of this mouse
model for testing new pharmacological treatments.
Repetitive behavior is recognized as reflecting a disruption of
the coordinated function of the cortico-striatal circuit (Albin et al.,
1989). In brief, two main pathways compose this system: the
direct pathway, which promotesmotor behavior, and the indirect
pathway, which inhibits it (Gerfen et al., 1990). In general, stereo-
typies indicate an unbalanced activity of this network favoring
the direct pathway (Lewis et al., 2007). At the neuronal level,
the ultimate firing output to the direct and indirect pathways is
determined by excitatory inputs from cortex and thalamus and
inhibitory inputs from local interneurons within the striatum
(Kreitzer and Malenka, 2008). Interestingly, PVALB+ fast-spiking
interneurons, which are the main source of inhibitory input in
Figure 7. Risperidone Rescues Hyperactivity and
Repetitive Behavior/Perseveration in Cntnap2/
Mice
(A and B) Open field test. Distance traveled (A) and velocity
(B) for vehicle- (PBS) and drug-treated WT and KO mice
(20 min).
(C) Nesting behavior. Risperidone improves the nesting
score of Cntnap2/ mice.
(D) Hot plate. Risperidone did not have an effect in the
hyperreactivity to thermal stimuli.
(E) Grooming behavior is reduced in risperidone-treated
mutant mice (10 min).
(F) Risperidone improved spontaneous alternation of
mutant mice.
(G) Drug treatment did not have an effect in the three-
chamber social interaction test.
n = 10 mice/genotype and treatment condition. Data
are presented as mean ± SEM. *p < 0.05, **p < 0.01,
***p < 0.001.the cortico-striatal circuit, have recently been shown to target
mainly the direct pathway (Gittis et al., 2010). Therefore, the
reduced number of this type of interneuron in Cntnap2/ mice
likely results in overactivation of this pathway, leading to hyper-
activity and repetitive behavior. Indeed, risperidone is known to
potentiate the indirect pathway, which likely rebalances the
activity of this network, alleviating these behaviors.
Nest building has also been shown to be related to the
dopaminergic pathway (Szczypka et al., 2001) and has been
reported as disrupted in mice with hyperactivity (Kwon et al.,
2006; Zhou et al., 2010). That risperidone also normalized the
nesting ability in KO mice provides additional evidence forCell 147, 235–abnormal striatal dopaminergic function in
this model. Exploration of cortico-striatal func-
tion in Cntnap2/ mice will provide a better
understanding of the neural basis of repetitive
behavior in ASD. In addition, the dissociation
between repetitive and social behavior with
regards to treatment response suggests that
Cntnap2/ mice will be useful for dissect-
ing the distinct circuitries involved in these
core components of autistic-related abnormal
behavior. Finally, because understanding of
CNTNAP2 function was previously focused
primarily on postnatal development, these
data set a new direction for investigation
of CNTNAP2’s role during development and
in the formation and function of neuronal
circuits.
EXPERIMENTAL PROCEDURES
Mice
Cntnap2mutant and WT mice were obtained from hetero-
zygous crossings and were born with the expected
Mendelian frequencies. The day of vaginal plug detection
was designated as E0.5 and the day of birth as P0.
The three obtained genotypes were housed together
with three to four same sex mice per cage. They were
kept in 12 hr light/12 hr dark cycle and had ad-lib accessto food and water. All procedures involving animals were performed in accor-
dance with the UCLA animal research committee.
Western Blot, In Situ Hybridization, and Immunohistochemistry
Western blot, in situ hybridization, and immunohistochemistry were performed
using standard methods. See Extended Experimental Procedures for details.
BrdU Labeling
Timed pregnant mice (E16.5) received a single i.p. injection of BrdU (50 mg/kg
body weight, Sigma).
Imaging and Cell Counts
Images were acquired with a Zeiss LSM-510 laser-scanning confocal micro-
scope. Eight anatomically matched sections from at least three mice per246, September 30, 2011 ª2011 Elsevier Inc. 243
genotype were selected for cell counting. For cortical images, cells were
counted in matched areas of fixed size (1.2 mm wide) in each hemisphere of
somatosensory cortex. The boundaries of the different cortical layers were
determined by counterstaining each section with DAPI.
Weighted Gene Coexpression Network Analysis
The original microarray data set was deposited by Sugino et al. (2006) in the
Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE2882). Weighted gene coexpression network analysis (WGCNA)
was performed as previously described (Winden et al., 2009). More detailed
conditions are included in the Extended Experimental Procedures.
Electroencephalographic Recordings
Mice were deeply anesthetized with isoflurane, and microelectrodes (0.005
inch diameter) were implanted over right frontal and parietal cortices. Mice
were allowed to recover for 48 hr, and EEG activity was recorded daily for
up to 2 weeks.
In Vivo Two-Photon Calcium Imaging
Neuronal activity was imaged using a calcium indicator injected in layer II/III of
somatosensory cortex in young adult mice (2–4 months of age). See the
Extended Experimental Procedures for details.
Behavioral Tests
Ten mice per genotype were evaluated for each behavioral test. Mice were
tagged with either an ear tag number or a toe tattoo (in the case of pups).
Experimenters were blinded to the genotype during testing. Behavioral tests
were performed in the UCLA behavioral test core and analyzed with TopScan
(Clever Sys, Inc.) automated system. UsV were analyzed with Avisoft sound
analysis and synthesis software for laboratory animals.
Morris Water Maze
The MWM test was performed as described elsewhere (Vorhees andWilliams,
2006). In brief, mice were trained to locate a hidden platform based on distal
visual cues to escape from the pool. Mice received four training trials per
day (with different start points) for 5 consecutive days. On day 6, the platform
was removed and a probe test was performed. The next day, the platform was
moved to the opposite quadrant and the reversal task of the test was started.
Mice received again four training trials per day to locate the new platform.
A probe test was performed on day 10.
T Maze Spontaneous Alternation
Micewere placed on the base of a Tmaze andwere given the choice to explore
either the right or left arm of the maze for ten consecutive trials. A choice was
assumed to be made when the mice stepped with the four paws into an arm.
At that moment, the gate to that arm was closed and the animal was allowed
to explore the arm for 5 s.
Ultrasonic Vocalization
Pups were removed from the dam and placed in individual heated sound proof
chambers equipped to record ultrasonic vocalization (UsV) for 5 min. To avoid
potential confounding effects due to temperature, the room was maintained at
21C and body temperature was measured with a rectal probe after 5 min of
the test at P6 (35C in both genotypes).
Juvenile Play
Mice at age P21 were placed in a cage (previously habituated to it) with an
unfamiliar mouse matched in genotype and sex for 10 min. The time mice
were engaged in social interaction (nose-to-nose sniffing, nose-to-anus
sniffing, following or crawling on/under each other), and the time mice spent
engaged in repetitive behaviors (grooming and digging) was measured by
a human observer (Silverman et al., 2010).
Three-Chamber Social Interaction Test
The social interaction test was performed as previously described (Silverman
et al., 2010). In brief, after habituation, a mouse was placed in the central
chamber of a clear Plexiglas box divided into three interconnected chambers244 Cell 147, 235–246, September 30, 2011 ª2011 Elsevier Inc.and was given the choice to interact with either an empty wire cup (located in
one side chamber) or a similar wire cup with an unfamiliar mouse inside
(located in the opposite chamber). Time sniffing each cup was measured.
Drug Administration
Risperidone (0.2 mg/kg, Sigma) was administered by a daily i.p. injection in
a volume of 10 ml/kg for 7 consecutive days. Behavioral tests were performed
on days 8, 9, and 10. Mice also received drug treatment during these days
approximately 1 hr prior to testing.
Statistical Analyses
All results are expressed asmean ± SEM. For cell quantifications and neuronal
synchrony comparisons between groups, a one-way ANOVA was used. To
compare cell distributions within the cortical layers, we used two-way
ANOVA. For behavioral tests, either one- or two-way ANOVA with repeated
measures followed by Bonferroni-Dunn posthoc tests, when applied, were
used.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, three tables, and one movie and can be found with this article online
at doi:10.1016/j.cell.2011.08.040.
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